Evaluation of NucliSens EasyQ™ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia

Journal of Clinical Virology

Volumn 38, Issue 1, 2007, Pages 39-43

  Lam, H Y ^a   Chen, J H K ^a   Wong, K H ^b   Chan, K ^b   Li, P ^c   Lee, M P ^c   Tsang, D N ^c   Yuen, K Y ^a   Yam, W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

COBAS Amplicor ; HIV 1; NucliSens EasyQ ; Subtype diversity; Viral load monitoring

Indexed keywords

VIRUS RNA;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; CAMBODIA; CONTROLLED STUDY; CORRELATION COEFFICIENT; GENE MUTATION; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONITORING; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SOUTHEAST ASIA; STATISTICAL SIGNIFICANCE; VIRUS LOAD; VIRUS RESISTANCE; VIRUS STRAIN;

CAMBODIA; HIV INFECTIONS; HIV-1; HONG KONG; HUMANS; RANDOM ALLOCATION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 33845287241     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.10.002     Document Type: Article

References (20)

1. Bland J.M., and Altman D.G. Measuring agreement in method comparison studies. Stat Meth Med Res 8 2 (1999) 135-160
2. de Mendoza C., Koppelman M., Montes B., Ferre V., Soriano V., Cuypers H., et al. Multicenter evaluation of the NucliSens EasyQ HIV-1 version 1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Meth 127 1 (2005) 54-59
3. Dyer J.R., Pilcher C.D., Shepard R., Schock J., Eron J.J., and Fiscus S.A. Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 37 2 (1999) 447-449
4. Ginocchio C.C., Tetali S., Washburn D., Zhang F., and Kaplan M.H. Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays. J Clin Microbiol 37 4 (1999) 1210-1212
5. Mellors J.W., Munoz A., Giorgi J.V., Margolick J.B., Tassoni C.J., Gupta P., et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126 12 (1997) 946-954
6. Murphy D.G., Cote L., Fauvel M., Rene P., and Vincelette J. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 38 11 (2000) 4034-4041
7. O'Brien W.A., Hartigan P.M., Daar E.S., Simberkoff M.S., and Hamilton J.D. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Ann Intern Med 126 12 (1997) 939-945
8. Oelrichs R.B., and Crowe S.M. The molecular epidemiology of HIV-1 in South and East Asia. Curr HIV Res 1 2 (2003) 239-248
9. Powderly W.G., Saag M.S., Chapman S., Yu G., Quart B., and Clendeninn N.J. Predictors of optimal virological response to potent antiretroviral therapy. AIDS 13 14 (1999) 1873-1880
10. Raboud J.M., Montaner J.S., Conway B., Rae S., Reiss P., Vella S., et al. Suppression of plasma viral load below 20 copies/mL is required to achieve a long-term response to therapy. AIDS 12 13 (1998) 1619-1624
11. Ruxrungtham K., Brown T., and Phanuphak P. HIV/AIDS in Asia. Lancet 364 9428 (2004) 69-82
12. Stevens W., Wiggill T., Horsfield P., Coetzee L., and Scott L.E. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa. J Virol Meth 124 1/2 (2005) 105-110
13. Su L., Graf M., Zhang Y., von Briesen H., Xing H., Kostler J., et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol 74 23 (2000) 11367-11376
14. Sun R., Ku J., Jayakar H., Kuo J.C., Brambilla D., Herman S., et al. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 36 10 (1998) 2964-2969
15. Van Beuningen R., Marras S.A., Kramer F.R., Oosterlaken T., Weusten J., Borst G., et al. Development of a high throughput detection system for HIV-1 using real-time NASBA based on molecular beacons. In: Raghavachari R., and Tan W.H. (Eds). Genomics and proteomics technologies, Proceedings of SPIE, vol. 4264 (2001), Society of Photo-optical Instrumentation Engineers, Washington, DC 66-71
16. Weusten J.J., Carpay W.M., Oosterlaken T.A., van Zuijlen M.C., and van de Wiel P.A. Principles of quantitation of viral loads using nucleic acid sequence-based amplification in combination with homogeneous detection using molecular beacons. Nucl Acids Res 30 6 (2002) e26
17. Yam W.C., Chen J.H., Wong K.H., Chan K., Cheng V.C., Lam H.Y., et al. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong. J Clin Virol 35 (2006) 454-457
18. Yang R., Kusagawa S., Zhang C., Xia X., Ben K., and Takebe Y. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol 77 1 (2003) 685-695
19. Yao J., Liu Z., Ko L.S., Pan G., and Jiang Y. Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Meth 129 1 (2005) 40-46
20. Yeni P.G., Hammer S.M., Hirsch M.S., Saag M.S., Schechter M., Carpenter C.C., et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 292 2 (2004) 251-265